Therapie der funktionellen Obstipation in Schwangerschaft und Stillzeit

In der Schwangerschaft ist die Transitzeit im Darm verzögert, weshalb bis zu ⅓ der Schwangeren im 2. und 3. Trimenon über Obstipation klagt mit deutlicher Einschränkung der Lebensqualität. Allerdings gibt es nicht so viel Auswahl an gut untersuchten und sicheren Laxanzien für Schwangere und Stillende – zum einen wegen des Risikos für Tenesmen, zum anderen wegen eventueller Plazentagängigkeit oder Übergangs in die Muttermilch.

• Literatur

• 1 Lembo A, Camilleri M. Chronic constipation. N Engl J Med 2003; 349: 1360-1368
• 2 Jewell D, Young G. Interventions for treating constipation in pregnancy. Cochrane Database Syst Rev 2001; (02) CD001142
• 3 Cullen G, OʼDonoghue D. Constipation and pregnancy. Best Pract Res Clin Gastroenterol 2007; 21: 807-818
• 4 Longstreth GF, Thompson WG, Chey WD. et al. Functional bowel disorders. Gastroenterology 2006; 130: 1480-1491
• 5 Drossman DA, Dumitrascu DL. Rome III: New standard for functional gastrointestinal disorders. J Gastrointestin Liver Dis 2006; 15: 237-241
• 6 Pare P, Ferrazzi S, Thompson WG. et al. An epidemiological survey of constipation in canada: definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol 2001; 96: 3130-3137
• 7 Locke 3rd GR, Pemberton JH, Phillips SF. AGA technical review on constipation. Gastroenterology 2000; 119: 1766-1778
• 8 Degen L, Dederding J-P, Bauerfeind P. et al. Fakten und Mythen zur Obstipation – State of the art. Schweiz Med Forum 2008; 8: 913-918
• 9 [Anonymous] Pregnancy labeling. FDA Drug Bull 1979; 9: 23-24
• 10 Doering PL, Boothby LA, Cheok M. Review of pregnancy labeling of prescription drugs: is the current system adequate to inform of risks?. Am J Obstet Gynecol 2002; 187: 333-339
• 11 Kweder SL. Drugs and biologics in pregnancy and breastfeeding: FDA in the 21st century. Birth Defects Res A Clin Mol Teratol 2008; 82: 605-609
• 12 Law R, Bozzo P, Koren G. et al. FDA pregnancy risk categories and the CPS: do they help or are they a hindrance?. Can Fam Physician 2010; 56: 239-241
• 13 Tedesco FJ, DiPiro JT. Laxative use in constipation. American College of Gastroenterologyʼs Committee on FDA-related Matters. Am J Gastroenterol 1985; 80: 303-309
• 14 Trottier M, Erebara A, Bozzo P. Treating constipation during pregnancy. Can Fam Physician 2012; 58: 836-838
• 15 Manz M, Meier R. Chronische Obstipation, Ursachen, Diagnostik und Therapie. SZE 2008; 2: 29-33
• 16 Voderholzer WA, Schatke W, Mühldorfer BE. et al. Clinical response to dietary fiber treatment of chronic constipation. Am J Gastroenterol 1997; 92: 95-108
• 17 Tytgat GN, Heading RC, Müller-Lissner S. et al. Contemporary understanding and management of reflux and constipation in the general population and pregnancy: a consensus meeting. Aliment Pharmacol Ther 2003; 18: 291-301
• 18 Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002; 106: 2747-2757
• 19 Nahrstedt A. Flachs, Hornklee, Widderchen und Blausäure. Cyanogenese in Schmetterlingen. Biol Unserer Zeit 1988; 18: 105-109
• 20 Tou JC, Chen J, Thompson LU. Flaxseed and its lignan precursor, secoisolariciresinol diglycoside, affect pregnancy outcome and reproductive development in rats. J Nutr 1998; 128: 1861-1868
• 21 Francois CA, Connor SL, Bolewicz LC. et al. Supplementing lactating women with flaxseed oil does not increase docosahexaenoic acid in their milk. Am J Clin Nutr 2003; 77: 226-233
• 22 Suhonen R, Kantola I, Bjorksten F. Anaphylactic shock due to ingestion of psyllium laxative. Allergy 1983; 38: 363-365
• 23 Vaswani SK, Hamilton RG, Valentine MD. et al. Psyllium laxative-induced anaphylaxis, asthma, and rhinitis. Allergy 1996; 51: 266-268
• 24 Jick H, Holmes LB, Hunter JR. et al. First-trimester drug use and congenital disorders. J Am Med Assoc 1981; 246: 343-346
• 25 Hawley PH, Byeon JJ. A comparison of sennosides-based bowel protocols with and without docusate in hospitalized patients with cancer. J Palliat Med 2008; 11: 575-581
• 26 McRorie JW, Daggy BP, Morel JG. et al. Psyllium is superior to docusate sodium for treatment of chronic constipation. Aliment Pharmacol Ther 1998; 12: 491-497
• 27 Tarumi Y, Wilson MP, Szafran O. et al. Randomized, double-blind, placebo-controlled trial of oral docusate in the management of constipation in hospice patients. J Pain Symptom Manage 2013; 45: 2-13
• 28 Sharif F, Crushell E, OʼDriscoll K. et al. Liquid paraffin: a reappraisal of its role in the treatment of constipation. Arch Dis Child 2001; 85: 121-124
• 29 Gal-Ezer S, Shaoul R. The safety of mineral oil in the treatment of constipation – a lesson from prolonged overdose. Clin Pediatr (Phila) 2006; 45: 856-858
• 30 Aselton P, Jick H, Milunsky A. et al. First-trimester drug use and congenital disorders. Obstet Gynecol 1985; 65: 451-455
• 31 Schindler AM. Isolated neonatal hypomagnesaemia associated with maternal overuse of stool softener. Lancet 1984; 2: 822
• 32 Carulli N, Salvioli GF, Manenti F. Absorption of lactulose in man. Digestion 1972; 6: 139-145
• 33 DiPiro JT, Michael KA, Clark BA. et al. Absorption of polyethylene glycol after administration of a PEG-electrolyte lavage solution. Clin Pharmacol 1986; 5: 153-155
• 34 Attar A, Lemann A, Ferguson A. et al. Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut 1999; 44: 226-230
• 35 Christie AH, Culbert P, Guest J. Economic impact of low dose polyethylene glycol 3350 plus electrolytes compared with lactulose in the management of idiopathic constipation in the UK. Pharmacoeconomics 2002; 20: 49-60
• 36 Hardcastle JD, Wilkins JL. The action of sennosides and related compounds on human colon and rectum. Gut 1970; 11: 1038-1042
• 37 Hervé S, Savoye G, Behbahani A. et al. Results of 24-h manometric recording of colonic motor activity with endoluminal instillation of bisacodyl in patients with severe chronic slow transit constipation. Neurogastroenterol Motil 2004; 16: 397-402
• 38 Müller-Lissner SA, Akkermans LMA. et al. Hrsg. Interdisziplinäre Gastroenterologie. Berlin, Heidelberg: Springer; 1989: 45-47
• 39 Tunaru S, Althoff TF, Nüsing RM. et al. Castor oil induces laxation and uterus contraction via ricinoleic acid activating prostaglandin EP3 receptors. Proc Natl Acad Sci U S A 2012; 109: 9179-9184
• 40 Watson WC, Gordon jr. RS, Karmen A. et al. The absorption and excretion of castor oil in man. J Pharm Pharmacol 1963; 15: 183-188
• 41 Acs N, Bánhidy F, Puhó EH. et al. Senna treatment in pregnant women and congenital abnormalities in their offspring – a population-based case-control study. Reprod Toxicol 2009; 28: 100-104
• 42 Krumbiegel G, Schulz HU. Rhein and aloe-emodin kinetics from senna laxatives in man. Pharmacology 1993; 47: 120-124
• 43 Cameron BD, Phillips MW, Fenerty CA. Milk transfer of rhein in the rhesus monkey. Pharmacology 1988; 36 (Suppl. 01) 221-225
• 44 Faber P, Strenge-Hesse A. Relevance of rhein excretion into breast milk. Pharmacology 1988; 36 (Suppl. 01) 212-220
• 45 Roth W, Beschke K. Pharmacokinetics and laxative effect of bisacodyl following administration of various dosage forms. Arzneimittelforschung 1988; 38: 570-574
• 46 Flig E, Hermann TW, Zabel M. Is bisacodyl absorbed at all from suppositories in man?. Int J Pharm 2000; 196: 11-20
• 47 Friedrich C, Richter E, Trommeshauser D. et al. Absence of excretion of the active moiety of bisacodyl and sodium picosulfate into human breast milk: an open-label, parallel-group, multiple-dose study in healthy lactating women. Drug Metab Pharmacokinet 2011; 26: 458-464
• 48 Jiao HY, Kim DH, Ki JS. et al. Effects of lubiprostone on pacemaker activity of interstitial cells of cajal from the mouse colon. Korean J Physiol Pharmacol 2014; 18: 341-346
• 49 Ke M, Tack J, Quigley EM. et al. Effect of prucalopride in the treatment of chronic constipation in Asian and Non-Asian women: A pooled analysis of 4 randomized, placebo-controlled studies. J Neurogastroenterol Motil 2014; 20: 458-468
• 50 Love BL, Johnson A, Smith LS. Linaclotide: a novel agent for chronic constipation and irritable bowel syndrome. Am J Health Syst Pharm 2014; 71: 1081-1091
• 51 Schaefer C, Spielmann H, Vetter K, Weber-Schöndorfer C. Hrsg. Arzneimittel in Schwangerschaft und Stillzeit. 8. Aufl.. München: Urban & Fischer/Elsevier; 2012: 98-100
• 52 Spielmann H, Steinhoff R. Hrsg. Taschenbuch der Arzneimittelverordnung in Schwangerschaft und Stillperiode. 3. Aufl.. Stuttgart, New York: Gustav Fischer; 1990: 164-167
• 53 Marteau P, Cuillerier E, Meance S. et al. Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study. Aliment Pharmacol Ther 2002; 16: 587-593
• 54 Müller-Lissner SA, Kamm MA, Scarpignato C. et al. Myths and misconceptions about chronic constipation. Am J Gastroenterol 2005; 100: 232-242
• 55 Müller-Lissner SA, Kaatz V, Brandt W. et al. The perceived effect of various foods and beverages on stool consistency. Eur J Gastroenterol Hepatol 2005; 17: 109-112